Home › Endometriumkanker › Virginia › Arlington
Endometriumkanker klinische studies in Arlington, VA
39 studies voor Endometriumkanker zoeken deelnemers op locaties in en rond Arlington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- Inova Fairfax Hospital, Falls Church · 4 mijl verwijderd
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RekruterenFase 1/2
- Research Site, Fairfax · 11 mijl verwijderd
A Study of PHST001 in Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology - Virginia, Fairfax · 11 mijl verwijderd
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Inova Schar Cancer Institute, Fairfax · 11 mijl verwijderd
- NEXT Virginia, Fairfax · 11 mijl verwijderd
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruterenFase 1
- Site 04, Fairfax · 11 mijl verwijderd
Study of AVZO-021 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mijl verwijderd
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RekruterenFase 3
- Inova Schar Cancer Institute ( Site 6003), Fairfax · 11 mijl verwijderd
- Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax · 11 mijl verwijderd
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruterenFase 1/2
- NEXT Oncology, Fairfax · 11 mijl verwijderd
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
RekruterenFase 1
- NEXT Oncology, Fairfax · 11 mijl verwijderd
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekruterenFase 3
- Research Site, Fairfax · 11 mijl verwijderd
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruterenFase 1
- Inova Schar Cancer Institute, Falls Church · 4 mijl verwijderd
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruterenFase 1
- Normunity Investigational Site, Fairfax · 11 mijl verwijderd
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekruterenFase 3
- Research Site, Falls Church · 4 mijl verwijderd
- Research Site, Fairfax · 11 mijl verwijderd
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruterenFase 2
- 522, Fairfax · 11 mijl verwijderd
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mijl verwijderd
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruterenFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mijl verwijderd
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- NEXT, Fairfax · 11 mijl verwijderd
A Study of LY4175408 in Participants With Advanced Cancer
RekruterenFase 1
- NEXT Virginia, Fairfax · 11 mijl verwijderd
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekruterenFase 1
- NEXT Texas LLC - Virginia, Fairfax · 11 mijl verwijderd
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruterenFase 1
- Dren Investigational Site, Fairfax · 11 mijl verwijderd
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
RekruterenFase 2
- Virginia Cancer Specialists, P.C., Fairfax · 11 mijl verwijderd
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RekruterenFase 1
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
RekruterenFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mijl verwijderd
Endometriumkanker studies in andere steden
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Oklahoma City, OK25 studies
- Chicago, IL25 studies
- Queens, NY25 studies
Andere studies in Arlington
- Niet-kleincellige longkanker104 studies
- Metastatische kanker53 studies
- Colorectale kanker52 studies
- Kanker (alle vormen)48 studies
- Borstkanker47 studies
- Eierstokkanker46 studies
- Longkanker41 studies
- Aldermeesklierkanker33 studies
- Plaveiselcelcarcinoom van hoofd en hals26 studies
- Kleincellige longkanker23 studies
- Maagkanker20 studies
- Drievoudig negatieve borstkanker20 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.